Post-transplant monitoring of chimerism by lineage-specific analysis.
Molecular surveillance of hematopoietic chimerism is an important part of the routine diagnostic program in patients after allogeneic stem cell transplantation. Chimerism testing permits early prediction and documentation of successful engraftment and facilitates early risk assessment of impending graft rejection. In patients transplanted for treatment of malignant hematologic disorders, monitoring of chimerism can provide an early indication of incipient disease relapse. The investigation of chimerism has therefore become an indispensable tool for the management of patients during the post-transplant period. Increasing use of reduced-intensity conditioning, which is associated with prolonged duration of mixed hematopoietic chimerism, has further increased the clinical importance of chimerism analysis. At present, the most commonly used technical approach to the investigation of chimerism is microsatellite analysis by polymerase chain reaction. The investigation of chimerism within specific leukocyte subsets isolated from peripheral blood or bone marrow samples by flow sorting- or magnetic bead-based techniques provides more specific information on processes underlying the dynamics of donor/recipient chimerism. Moreover, cell subset-specific analysis permits the assessment of impending complications at a significantly higher sensitivity, thus providing a basis for earlier treatment decisions.
Children's Cancer Research Institute (CCRI), Vienna, Austria.
Sandra
S
Preuner
Thomas
T
Lion
D019070:Cell Lineage / Q000235:genetics*; D006084:Graft Rejection / Q000175:diagnosis / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000235:genetics / Q000628:therapy; D007962:Leukocytes / Q000378:metabolism; D016133:Polymerase Chain Reaction / Q000379:methods*; D018183:Transplantation Chimera / Q000235:genetics*; D014184:Transplantation, Homologous